Pace Diagnostics is an emerging biotechnology company focused on the research, development, licensing, manufacturing and marketing of cutting-edge diagnostics. Formed on the culmination of decades of basic and applied research, supported by grants and contracts from the US Federal Government.
Our vision is to create breakthrough point-of-care (POC) diagnostics to revolutionize improvements in healthcare for better living.
Through our novel and potent biomarkers in combination with innovative diagnostics platforms, we are developing a comprehensive portfolio of point-of-care rapid diagnostics. Our lead products are Tuberculosis Triage/Screening Test, COVID-19 Antigen Rapid Detection Test, and Lung Cancer Early Detection Test